Epilepsy in pregnancy: Best evidence for care

Journal of Perinatal and Neonatal Nursing

Volumn 27, Issue 3, 2013, Pages 217-224

  Ruth, Donna Jean ^a   Barnett, James ^a  

^a Association of Women's Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ARTICLE; EPILEPSY; EVIDENCE BASED MEDICINE; FEMALE; FETUS DISEASE; HIGH RISK PREGNANCY; HUMAN; INCIDENCE; METHODOLOGY; NEWBORN; NEWBORN DISEASE; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL CARE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ANTICONVULSANTS; EPILEPSY; EVIDENCE-BASED MEDICINE; FEMALE; FETAL DISEASES; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PRENATAL CARE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84881579247     PISSN: 08932190     EISSN: 15505073     Source Type: Journal    
DOI: 10.1097/JPN.0b013e31829d1d29     Document Type: Article

References (35)

1. Kulaga S, Sheehy O, Zargarzadeh AH, Moussally K, Berard A. Antiepileptic drug use during pregnancy: perinatal outcomes. Seizure. 2011;20:667-672.
2. Caughey AB. Seizure disorders in pregnancy. http://emedicine.medscape. com/article/272050-overview. Accessed January 31, 2013.
3. Krishnamurthy KB. Managing epilepsy during pregnancy: assessing risk and optimizing care. Curr Treat Options Neurol. 2012;14:348-355.
4. Borthen I, Eide MG, Daltveit AK, Gilhus NE. Obstetric outcomes in women with epilepsy: a hospital-based, retrospective study. Br J Obstet Gynecol. 2011;118:956-965.
5. McAuley JW, Patankar C, Lang C, Prasad M. Evaluating the concerns of pregnant women with epilepsy: a focus group approach. Epilepsy Behav. 2012;24:246-248.
6. Buelow JM, Long L, Rossi AM, Gilbert KL. Epilepsy. In: Bader MK, Littlejohns LR, eds. AANN Core Curriculum for Neuroscience Nursing. 4th ed. St Louis, MO: WB Saunders; 2004:586-618
7. Malgaard-Nielsen D, Hviid A. Newer generation antiepileptic drugs and the risks of major birth defects. JAMA. 2011;305(19):1996-2002.
8. Meadaor K, Reynolds MW, Crean S, Fahrback K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res. 2008;81(1):1-13.
9. Tomson T, Battino D. Teratogenic effects of antiepileptic drugs. Lancet Neurol. 2012;11:803-813.
10. Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy register. J Neurosurg Psychiatry. 2006;77(2):193-198. (Pubitemid 43220841)
11. Harden CL, Meador KJ, Pennell PB, et al. Management issues for women with epilepsy - focus on pregnancy (an evidencebased review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73:132-141.
12. Thomas SV, Syam U, Devi JS. Predictors of seizures during pregnancy in women with epilepsy. Epilepsia. 2012;53(5):e85-e88.
13. EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP Epilepsy Pregnancy Registry. Neurology. 2006;66(3):354-360.
14. Harden CL, Hopp J, Ting TY, et al. Management issues for women with epilepsy - focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73: 126-132.
15. Williams J, Myson V, Steward S, et al. Self-discontinuation of anti-epileptic medication in pregnancy: detection by hair analysis. Epilepsia. 2002;43:824-832.
16. Samuels P, Niebyl Jr. Neurologic Disorders in Obstetrics Normal and Problem Pregnancies. 6th ed. Philadelphia, PA: Elsevier/Saunders; 2012.
17. Harden CL, Pennell PB, Koppel BS, et al. Management issues for women with epilepsy - focus on pregnancy (an evidencebased review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73:142-149.
18. Meador KJ, Baker GA, Btrning N, et al. Fetal antiepileptic drug exposure and verbal versus nonverbal abilities at three years of age. Brain. 2011;134(pt 2):396-404.
19. Meador KJ, Baker GA, Btrning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age six years: a prospective observational study [published online ahead of print January 23, 2013]. Lancet Neurol. http://www.thelancet.com/neurology. Accessed February 5, 2013.
20. Metcalfe A, Roberts JI, Abdulla F, et al. Patient knowledge about issues related to pregnancy in epilepsy: a crosssectional study. Epilepsy Behav. 2012;24:65-69.
21. Fairgrieve SD, Jackson M, Jonas P, et al. Population-based, prospective study of the care of women with epilepsy in pregnancy. BMJ. 2000;321:674-675.
22. Hvas CL, Henriksen TB, Ostergaaard JR, Dam M. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birth weight. Br J Obstet Gynecol. 2000;107:896-902. (Pubitemid 30417347)
23. Viinikainen K, Heinonen S, Eriksson K, Kalvainan R. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia. 2006;47:186-194.
24. Knight AH, Rhind EG. Epilepsy in pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia. 1975;16:99-104.
25. Hiilesmaa VK, Bardy A, Teramo K. Obstetric outcome in women with epilepsy. Am J Obstet Gynecol. 1985;152: 499-504. (Pubitemid 15039823)
26. Richmond JR, Krishnamoorthy P, Andermann E, Benjamin A. Epilepsy in pregnancy: an obstetric perspective. Am J Obstet Gynecol. 2004;190:371-379.
27. Borthen I, Eide MG, Veiby G, Daltviet AK, Gilhus NE. Complications during pregnancy in women with epilepsy. Epilespsia. 2009;116:1736-1742.
28. Thomas SV, Sindhu K, Ajakumar B, Sulekha Deve PS, Sujamol J. Maternal and obstetric outcome of women with epilepsy. Seizure. 2009;18:163-166.
29. Pilo C, Wide K, Winbladh B. Pregnancy, delivery, and neonatal complications after treatment with antiepileptic drugs. Acta Obstet Gynecol Scand. 2006;85:643-646. (Pubitemid 43995040)
30. Katz O, Levy A, Wizitzer A, Sheiner E. Pregnancy and perinatal outcome in epileptic women: a population-based study. J Matern Neonatal Med. 2006;19:21-25.
31. Endo SS, Hagimoto HH, Yamazawa HH, et al. Statistics on deliveries of mothers with epilepsy at Yokomata City University Hospitals. Epilepsia. 2004;45(suppl 8):42-47.
32. Linton A, Peterson MR. Effect of preexisting chronic disease on primary cesarean delivery rates by race for birth in U.S. military hospitals, 1999-2002. Birth. 2004;31:165-175.
33. Borthen I, Eide MG, Daltviet AK, Gilhus NE. Delivery outcome of women with epilepsy: a population-based cohort study. Br J Obstet Gynecol. 2010;117:1537-1543.
34. de Haan CJ, Edelbroek P, Segers J, et al. Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study. Neurology. 2004;63(3):571-573. (Pubitemid 39031398)
35. Pennell PB, Peng L, Newport DJ, et al. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology. 2008;70:2130-2136.